Want to see HK:8307 full AI Analyst Report?
Top Page
Medicskin Holdings Ltd.
(8307)
Select Model
Select Model
Rating:39Underperform
Price Target:
HK$0.10
▼(-40.59% Downside)
Action:Downgraded
Date:09/15/26
The score is weighed down primarily by elevated leverage and weakening revenue/margins in the financials, alongside a bearish technical setup (price below key moving averages, negative MACD, very low RSI). Valuation also detracts due to an extremely high P/E and no provided dividend yield support.
Positive Factors
Positive cash generation
Consistently positive operating and free cash flow indicates the business has generated cash internally across the reported period. Although FY2026 free cash flow declined materially, ongoing cash generation provides liquidity support and can help fund operations without relying entirely on external financing.
Negative Factors
Elevated balance-sheet leverage
Leverage remains materially above the company’s historical levels, increasing balance-sheet risk even after total debt declined from FY2025. High debt relative to equity can reduce financial flexibility, constrain investment choices, and make weaker operating performance more difficult to absorb.
Read all positive and negative factors
Positive Factors
Negative Factors
Positive cash generation
Consistently positive operating and free cash flow indicates the business has generated cash internally across the reported period. Although FY2026 free cash flow declined materially, ongoing cash generation provides liquidity support and can help fund operations without relying entirely on external financing.
Read all positive factors
Medicskin Holdings Ltd. (8307) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$41.66M
Dividend Yield7.69%
Average Volume (3M)7.20K
Price to Earnings (P/E)1050.0
Beta (1Y)0.37
Revenue Growth6.13%
EPS GrowthN/A
CountryHK
Employees27
SectorHealthcare
Sector Strength45
IndustryMedical - Care Facilities
Share Statistics
EPS (TTM)<0.01
Shares Outstanding396,736,000
10 Day Avg. Volume21,600
30 Day Avg. Volume7,200
Financial Highlights & Ratios
PEG Ratio-0.49
Price to Book (P/B)11.39
Price to Sales (P/S)1.24
P/FCF Ratio13.10
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Medicskin Holdings Ltd. Business Overview & Revenue Model
Company Description
Medicskin Holdings Limited, an investment holding company, provides medical skin care services in Hong Kong. The company operates Medicskin centers, which provides various medical skin care services for the treatment of skin diseases and problems,...
Medicskin Holdings Ltd. Financial Statement Overview
Summary
Income Statement
46
Neutral
Balance Sheet
32
Negative
Cash Flow
55
Neutral
| Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 47.87M | 45.11M | 49.88M | 45.54M | 49.15M |
| Gross Profit | 17.53M | 22.87M | 39.39M | 36.68M | 42.14M |
| EBITDA | 7.48M | 6.29M | 6.78M | 6.40M | 14.55M |
| Net Income | 936.00K | -3.38M | -3.05M | -3.54M | 3.92M |
Balance Sheet | |||||
| Total Assets | 51.07M | 57.44M | 40.06M | 46.37M | 56.67M |
| Cash, Cash Equivalents and Short-Term Investments | 29.46M | 17.34M | 6.93M | 6.37M | 15.47M |
| Total Debt | 17.57M | 22.79M | 5.76M | 11.93M | 18.67M |
| Total Liabilities | 45.84M | 53.25M | 32.48M | 35.21M | 42.49M |
| Stockholders Equity | 5.23M | 4.20M | 10.95M | 14.47M | 17.43M |
Cash Flow | |||||
| Free Cash Flow | 4.54M | 8.29M | 9.12M | 946.00K | 2.33M |
| Operating Cash Flow | 5.81M | 9.13M | 10.52M | 3.25M | 4.29M |
| Investing Cash Flow | -7.63M | -191.00K | -1.40M | -5.67M | -1.82M |
| Financing Cash Flow | -5.22M | 1.48M | -7.21M | -6.74M | -17.94M |
Medicskin Holdings Ltd. Technical Analysis
Negative
0.17
Price Trends
0.12
Negative
0.12
Negative
0.14
Negative
Market Momentum
>-0.01
Positive
7.83
Positive
-9.26
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8307, the sentiment is Negative. The current price of 0.17 is above the 20-day moving average (MA) of 0.12, above the 50-day MA of 0.12, and above the 200-day MA of 0.14, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 7.83 is Positive, neither overbought nor oversold. The STOCH value of -9.26 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:8307.
Medicskin Holdings Ltd. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | HK$735.48M | 298.70 | 0.20% | 1.92% | 20.54% | -96.74% | |
65 Neutral | HK$4.54B | 9.68 | 31.63% | 3.98% | 16.70% | 38.98% | |
55 Neutral | HK$62.95M | 3.91 | 12.17% | ― | 36.68% | ― | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | HK$1.03B | 31.33 | 1.27% | ― | ― | ― | |
39 Underperform | HK$41.66M | 1,050.00 | 0.90% | 7.69% | 6.13% | ― |
* Healthcare Sector Average
HK:8307
Medicskin Holdings Ltd.
0.11
-0.11
-51.83%
HK:1846
EuroEyes International Eye Clinic Limited
2.30
-0.78
-25.40%
HK:2135
Raily Aesthetic Medicine International Holdings Limited
0.11
-0.01
-9.09%
HK:2373
Beauty Farm Medical & Health Industry, Inc.
18.09
-17.12
-48.62%
HK:6639
Arrail Group Ltd.
1.83
-0.41
-18.35%
HK:2508
Saint Bella Inc.
2.95
-3.63
-55.17%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.